drugset / Trial / NCT05216744

Comparison of Efficacy of Two Combination Regimens for the Neisseria Gonorrhoeae and Chlamydia Coinfection

NCT05216744

Phase 2 Completed 125 enrolled Haiphong University of Medicine and Pharmacy
RandomizedParallel-groupOpen-labelTreatment

Summary

The frequency of Chlamydia trachomatis and Neisseria gonorrhoeae coinfection can vary depending on their individual incidence and prevalence rates.Single-agent therapy with ceftriaxone is the preferred regimen for treatment of gonococcal infections. If an injectable cephalosporin is not available, cefixime is the only oral cephalosporin that can be used for gonococcal therapy. Doxycycline was recommended for presumptive treatment of chlamydia in nonpregnant individuals with gonococcal infection. The study is conducted to evaluate the effectiveness of two regimens in combination with doxycycline with cefixime or ceftriaxone.

Timeline

Start
2021-07-15
Primary completion
2022-02-15
Completion
2022-02-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cefixime Other / unclassified 800 mg Oral
Subject Ceftriaxone Other / unclassified 1000 mg Intravenous
Background Doxycycline Small molecule 100 mg Oral